Literature DB >> 14278005

PARTIAL SUPPRESSION OF MALARIA PARASITES, AND OF THE TRANSMISSION OF MALARIA, IN AEDES AEGYPTI (L.) DOUBLY-INFECTED WITH SEMLIKI FOREST VIRUS AND PLASMODIUM GALLINACEUM BRUMPT.

D S BERTRAM, M G VARMA, J R BAKER.   

Abstract

Laboratory experiments were undertaken with Aedes aegypti infected with both Semliki Forest virus (SFV) from infant mice and Plasmodium gallinaceum from fowls to determine if such double infection of mosquitos suppressed their ability to transmit the malaria parasite, a possibility suggested to explain reduction in malaria transmission in Uganda in 1960 when Anopheles funestus and Anopheles gambiae were transmitting both malaria and o'nyongnyong virus to the African population. In general, transmission of fowl malaria was not prevented by SFV infection in Aedes, although some malariometric indices, and consistently the mean oocyst count, were slightly lower in doubly-infected mosquitos than in controls. In one experiment, however, 60% of the Aedes infected 8 days previously with SFV died within 48 hours of ingesting a malarious meal. Mortality was selectively in favour of the survival of SFV-infected mosquitos negative for, or least heavily infected with, malaria; depression in the presence of the virus of the intensity of malaria infection in the individual Aedes also occurred. Some physiological factor-a stress in adult life or, possibly more important, suboptimal larval nutrition-appears to have been crucial to eliciting the adverse effect on the mosquitos themselves and on their malaria infections. Suppression of the development of a malaria parasite in a mosquito, and of malaria transmission, by concurrent infection of the vector with an arbovirus can happen, but is by no means inevitable.It is shown that a doubly-infected Aedes can transmit both Semliki Forest virus and P. gallinaceum simultaneously.

Entities:  

Keywords:  AEDES; ENCEPHALITIS VIRUSES; EXPERIMENTAL LAB STUDY; MALARIA CONTROL; MICE; POULTRY; SEMLIKI FOREST VIRUS

Mesh:

Year:  1964        PMID: 14278005      PMCID: PMC2555140     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  5 in total

1.  AN INVESTIGATION OF THE ANNUAL CYCLE OF MALARIA IN MASAKA DISTRICT (UGANDA).

Authors:  J DE ZULUETA; G W KAFUKO; J R CULLEN
Journal:  East Afr Med J       Date:  1963-10

2.  An observation on the possible effect of O'Nyong-Nyong fever on malaria.

Authors:  J DE ZULUETA; J P WOODALL; J R CULLEN; M C WILLIAMS; G W KAFUKO; J D GILLETT
Journal:  Bull World Health Organ       Date:  1962       Impact factor: 9.408

3.  The transmission of Semliki Forest virus by Aedes aegypti L.

Authors:  J P WOODALL; D S BERTRAM
Journal:  Trans R Soc Trop Med Hyg       Date:  1959-11       Impact factor: 2.184

4.  The transmission of Semliki Forest virus by Aedes aegypti.

Authors:  A M DAVIES; Y YOSHPE-PURER
Journal:  J Trop Med Hyg       Date:  1954-11

5.  Experimental studies of concurrent infection of canaries and of the mosquito Culex tarsalis with Plasmodium relictum and Western equine encephalitis virus.

Authors:  H C BARNETT
Journal:  Am J Trop Med Hyg       Date:  1956-01       Impact factor: 2.345

  5 in total
  3 in total

1.  A cytoplasmic polyhedrosis virus in midgut cells of Anopheles stephensi and in the sporogonic stages of Plasmodium berghei yoelii.

Authors:  R G Bird; C C Draper; D S Ellis
Journal:  Bull World Health Organ       Date:  1972       Impact factor: 9.408

2.  Current status of the immunology of malaria and of the antigenic analysis of plasmodia. A five-year review.

Authors:  A Zuckerman
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

3.  Defining malaria risks among forest workers in Aceh, Indonesia: a formative assessment.

Authors:  Lenny L Ekawati; Kelly C Johnson; Jerry O Jacobson; Carmen A Cueto; Iska Zarlinda; Iqbal R F Elyazar; Abdul Fatah; Maria E Sumiwi; Rintis Noviyanti; Chris Cotter; Jennifer L Smith; Farah N Coutrier; Adam Bennett
Journal:  Malar J       Date:  2020-11-30       Impact factor: 2.979

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.